Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
38 results
  1. MedlinePlus Drug Information: Thalidomide 
    https://medlineplus.gov/druginfo/meds/a699032.html
    Thalidomide is used along with dexamethasone to treat multiple myeloma in people who have been recently found ... that occur in people with Hansen's disease [leprosy]). Thalidomide is in a class of medications called immunomodulatory ...
  2. Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65924
    ... 96; P = .02).[ 32 ][ Level of evidence: 1iiA ] Thalidomide Thalidomide is a first-generation immunomodulatory agent that ...
  3. Acupuncture (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65714
    ... secondary outcomes ( NCT03582423 ).[ 101 ] CIPN from bortezomib or thalidomide Studies evaluating the effects of acupuncture on bortezomib and/or thalidomide -induced peripheral neuropathy have also shown promising results. ...
  4. Langerhans Cell Histiocytosis Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65799
    ... daily for at least 12 months.[ 10 ] Oral thalidomide. Oral thalidomide 50 mg to 200 mg nightly.[ 11 ] Oral thalidomide may be effective for both pediatric and adult ...
  5. SALL4-Related Disorders - GeneReviews® - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK1373
    ... criteria for Wildervanck syndrome [J Kohlhase, unpublished data]. Thalidomide embryopathy. From 1957 to 1962, malformed children were born to mothers who took the drug thalidomide for treatment of nausea and insomnia during pregnancy. ...
  6. Holt-Oram Syndrome - GeneReviews® - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK1111
    ... enal anomalies, and l imb anomalies) Teratogen exposure Thalidomide. Exposure to thalidomide in pregnancy places the fetus at risk for ... article : PMC2651674 ] [ PubMed : 19084512 ] Matthews SJ, McCoy C. Thalidomide: a review of approved and investigational uses. Clin ...
  7. Thrombocytopenia Absent Radius Syndrome - GeneReviews® - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK23758
    ... or an X-linked manner ( FANCB -related FA). Thalidomide embryopathy occurs secondarily to maternal ingestion of thalidomide. Affected children can have a pattern of limb, ...
  8. People and organisations involved in the production of this guideline - Addendum to Haematological Cancers - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK373292
    ... comparisons in myeloma patients of all ages of thalidomide, lenalidomide and bortezomib combinations and maintenance lenalidomide). Funded ... comparisons in myeloma patients of all ages of thalidomide, lenalidomide and bortezomib combinations and maintenance lenalidomide is ...
  9. Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66001
    ... also called biotherapy or biologic therapy. Immunomodulator therapy: Thalidomide , lenalidomide , and pomalidomide are immunomodulators used to treat ... patient's own stem cells. Immunotherapy: Immunotherapy with thalidomide, lenalidomide, or pomalidomide is given to treat amyloidosis. ...
  10. Childhood Vascular Tumors Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK363066
    ... tumors need to grow. The targeted therapy drugs thalidomide , sorafenib , pazopanib , and sirolimus are angiogenesis inhibitors used ... tumor when possible. Immunotherapy ( interferon ) and targeted therapy ( thalidomide , sorafenib , pazopanib , sirolimus ) for tumors that are likely ...
first · previous · 1 · 2 · 3 · 4 · next · last